List of Tables
    Table 1. Infectious Diseases Molecular Diagnostics Market Opportunities & Trends in Global Market
    Table 2. Infectious Diseases Molecular Diagnostics Market Drivers in Global Market
    Table 3. Infectious Diseases Molecular Diagnostics Market Restraints in Global Market
    Table 4. Key Players of Infectious Diseases Molecular Diagnostics in Global Market
    Table 5. Top Infectious Diseases Molecular Diagnostics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Infectious Diseases Molecular Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Infectious Diseases Molecular Diagnostics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Infectious Diseases Molecular Diagnostics Product Type
    Table 9. List of Global Tier 1 Infectious Diseases Molecular Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Infectious Diseases Molecular Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Infectious Diseases Molecular Diagnostics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
    Table 30. Roche Corporate Summary
    Table 31. Roche Infectious Diseases Molecular Diagnostics Product Offerings
    Table 32. Roche Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 33. Qiagen Corporate Summary
    Table 34. Qiagen Infectious Diseases Molecular Diagnostics Product Offerings
    Table 35. Qiagen Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 36. Illumina Corporate Summary
    Table 37. Illumina Infectious Diseases Molecular Diagnostics Product Offerings
    Table 38. Illumina Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 39. Abbott Corporate Summary
    Table 40. Abbott Infectious Diseases Molecular Diagnostics Product Offerings
    Table 41. Abbott Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 42. Hologic Corporate Summary
    Table 43. Hologic Infectious Diseases Molecular Diagnostics Product Offerings
    Table 44. Hologic Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 45. BioMerieux Corporate Summary
    Table 46. BioMerieux Infectious Diseases Molecular Diagnostics Product Offerings
    Table 47. BioMerieux Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 48. Danaher (Cepheid) Corporate Summary
    Table 49. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product Offerings
    Table 50. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 51. Myriad Genetics Corporate Summary
    Table 52. Myriad Genetics Infectious Diseases Molecular Diagnostics Product Offerings
    Table 53. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 54. DAAN Gene Corporate Summary
    Table 55. DAAN Gene Infectious Diseases Molecular Diagnostics Product Offerings
    Table 56. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 57. Agilent Corporate Summary
    Table 58. Agilent Infectious Diseases Molecular Diagnostics Product Offerings
    Table 59. Agilent Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 60. Genomic Health Corporate Summary
    Table 61. Genomic Health Infectious Diseases Molecular Diagnostics Product Offerings
    Table 62. Genomic Health Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 63. BD Corporate Summary
    Table 64. BD Infectious Diseases Molecular Diagnostics Product Offerings
    Table 65. BD Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
    Table 66. Foundation Medicine Corporate Summary
    Table 67. Foundation Medicine Infectious Diseases Molecular Diagnostics Product Offerings
    Table 68. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Infectious Diseases Molecular Diagnostics Segment by Type in 2021
    Figure 2. Infectious Diseases Molecular Diagnostics Segment by Application in 2021
    Figure 3. Global Infectious Diseases Molecular Diagnostics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Infectious Diseases Molecular Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Infectious Diseases Molecular Diagnostics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Infectious Diseases Molecular Diagnostics Revenue in 2021
    Figure 8. By Type - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Infectious Diseases Molecular Diagnostics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Infectious Diseases Molecular Diagnostics Revenue Market Share, 2017-2028
    Figure 12. US Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Infectious Diseases Molecular Diagnostics Revenue Market Share, 2017-2028
    Figure 16. Germany Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Infectious Diseases Molecular Diagnostics Revenue Market Share, 2017-2028
    Figure 24. China Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Infectious Diseases Molecular Diagnostics Revenue Market Share, 2017-2028
    Figure 30. Brazil Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Infectious Diseases Molecular Diagnostics Revenue Market Share, 2017-2028
    Figure 33. Turkey Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Infectious Diseases Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
    Figure 37. Roche Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Qiagen Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Illumina Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Abbott Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Hologic Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. BioMerieux Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Agilent Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Genomic Health Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. BD Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)